Inflation Reduction Act

The impact of the IRA has dominated many of our internal conversations and is likely to have a major impact on the healthcare landscape.

Our recent blog post (part of a series) provides an overview and our perspectives. ​

The Kaiser Family Foundation outlines the Medicare drug price negotiation timelines.​

This article discusses the unintended consequences.

Health Equity/Disparities

Health equity is so broad yet so integral to industry – whether it is culturally competent messaging, considering social determinants of health, and so much more.

We've seen firsthand how these initiatives can be a strategic tool to influencing stakeholders - check out our case example in women's health.

Here's an overview + framework  for the epidemiology of care.

This article discusses the effect of race and ethnicity on drug access.

AI Tools in Pharma Marketing

We believe AI tools have all the potential of early career teammates and just need the right guidance.

There are new AI tools every day - we found a website to keep you updated.

Speaking of which, here's a review on some of those.

Here is info on the potential of AI in pharmaceutical marketing (opening composed by ChatGPT).

Omnichannel Marketing

Omnichannel is atypical in the market access space, but we love learning and staying current. Here's what we're using to do that.

We found a guide to omnichannel marketing.

Here are 6 key principles to keep in mind for omnichannel marketing. 

Identify the right KPIs and metrics to track the ROI for your omnichannel approaches. 

This questionnaire can help you to define a roadmap.